Based on these findings, strategies are being materialized for blocking the CCR5 axis to uncover resulting antineoplastic effects and therapeutic relevance in cancers (Aldinucci and Casagrande 2018; Casagrande et al. 2019; Mencarelli et al. 2013; Ochoa-Callejero et al. 2013; Suarez-Carmona et al. 2019; Tan et al. 2009; Velasco-Velazquez et al. 2012). This evidence concerns the gene CCR5 and cancer.